Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender W… (NCT04275310) | Clinical Trial Compass
TerminatedNot Applicable
Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women
Stopped: Loss of funding
United States4 participantsStarted 2022-07-20
Plain-language summary
The purpose of this research study is to learn more about the economic situations, discrimination experiences, and risk behaviors of transgender women. The ultimate purpose of the study is to test an intervention to improve financial conditions and reduce HIV risk behaviors in transgender women.
Who can participate
Age range
18 Years – 45 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Transgender woman
* 18-45 years of age
At least one of the following economic vulnerability factors:
unemployment or underemployment \[less than 20 hours/week\], low income \[less than the Medicaid poverty threshold\], housing insecurity in the past year or food insecurity in the past year
• Behavioral vulnerability to HIV transmission (reported at least one episode of unprotected sex in prior 6 months or at least one other behavioral HIV transmission risk factor in the past 6 months: \[transactional sex, multiple sexual partners, 1-time sexual partner, sex under the influence of drugs or alcohol, sex with partner of unknown HIV status).
Exclusion Criteria:
* obvious signs of intoxication or cognitive impairment
* cannot speak English.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Employment Status
Timeframe: Baseline to up to 9 months
2
Change in Income
Timeframe: Baseline to up to 9 months
3
Change in Housing Stability
Timeframe: Baseline to up to 9 months
4
Change in Savings
Timeframe: Baseline to up to 9 months
5
Change in Self Reported HIV Risk Behavior
Timeframe: Baseline to up to 9 months
6
Change in Compliance With Recommended Biomedical Prevention or Treatment